Apogee Therapeutics, Inc.
APGE
Rang în acțiuni
#2345
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its... Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
Preț acțiune
$135.07
Ultima sincronizare: 2026-09-04
Capitalizare de piață
$8.36B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
152.56%
Țară
US
Tranzacționează Apogee Therapeutics, Inc. (APGE)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Apogee Therapeutics, Inc. (APGE)
Cel mai mare preț de închidere: $135.07 pe 2026-09-01
Cel mai mic preț de închidere: $20.79 pe 2023-07-01
Cel mai mic preț de închidere: $20.79 pe 2023-07-01
Istoric al prețului acțiunii pentru Apogee Therapeutics, Inc. din 2023 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | 17.47% |
| 2025 | 60.85% |
| 2024 | 96.41% |
| 2023 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
